| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Cathie Wood-led Ark Investment Management on Tuesday sold 1,102,797 shares in Signify Health Inc. (NYSE:SGFY), valued at $32.3 million, via two of its key exchange-traded funds.
The firm sold 670,690 shares in the healthcare company via its flagship ETF, the ARK Innovation ETF (NYSE:ARKK), and 432,107 shares via the ARK Genomic Revolution ETF (BATS:ARKG).
Signify Health made up just 0.37% of ARKK portfolio ahead of Tuesday's trade but it was the third-largest holding in ARKG with 4.71% weight.
See Also: Best Healthcare Stocks Right Now
The company reported a revenue of $246.20 million for the second quarter, according to the Benzinga Earnings Calendar, slightly missing analyst expectations of a $247.06 million revenue.
Signify Health shares shot up 41% in a single session on Aug. 22, when reports said Amazon.com Inc. (NASDAQ:AMZN) was interested in acquiring the company. Wood began trimming its stake in the company in the same session.
Ark also bought 316,223 shares in precision medicine company CareDx Inc. (NASDAQ:CDNA) and no other major trades were observed on Tuesday.
A day earlier, Wood — who has long backed electric vehicle market leader Tesla Inc. (NASDAQ:TSLA) — made her second-ever buy in legacy automaker General Motors Company (NYSE:GM), piling up 120,004 shares.
